Team

Dr. Marc Lehmann was already successfully involved as managing director and development manager in the establishment of two companies. He has many years of experience in the development of infectious diagnostics, in particular in the field of sepsis, and has a track record in CE-compliant product development and manufacturing. Within the scope of development, CE-marking and later marketing, he was significantly involved in the planning and execution of several clinical studies, including multi-centre studies. Dr. Lehmann is an inventor in several patents, has raised several million Euros in grants and won several innovation awards with his multinational teams.

Prof. Dr. Ulrich S. Schubert is Chair of Organic and Macromolecular Chemistry at the Friedrich Schiller University Jena, Director of the Jena Center for Soft Matter (JCSM) and one of the world's leading materials scientists and chemists.

• >1.100 publications
• Citations: 55,000 (Web of Science); 71,300 (Google Scholar)
• h-Index: 107 (Web of Sciences); 121 (Google Scholar)
• Since 2014 in the list of “Highly Cited Researcher”
• Spokesman of the DFG Collaborative Research Centre 1278 „PolyTarget“
• External scientific member of the Max Planck Institute for Colloids and Interfaces in Potsdam
• Thuringian Research Award for Applied Research
• Fellow of the National Academy of Inventors (NAI), USA
• Member of the German Academy of Science and Engineering (acatech)
• Federal Cross of Merit
• University teacher of the year 2019, German Association of University Professors and Lecturers / ZEIT

Prof. Dr. Michael Bauer is Director of the Clinic for Anaesthesiology and Intensive Care at the University Hospital Jena, Speaker of the " Center for Sepsis Control & Care (CSCC)" at the Faculty of Medicine of the Friedrich Schiller University Jena; and Deputy spokesperson of the DFG Collaborative Research Center 1278 PolyTarget "Polymer-based nanoparticle libraries for targeted anti-inflammatory strategies". His research group works on the translational development of adjuvant therapy options for septic organ failure.

• 255 publications; 32 reviews/ book contributions
• Citations: 15,300 (Web of Science), 25,560 (Google Scholar)
• h-Index: 53 (Web of Science), 67 (Google Scholar)

Dr. Anja Träger is Head of an independently financed junior research group (NanoMatFutur, BMBF) at the chair of Prof. Dr. Ulrich S. Schubert and member of the Jena Center for Soft Matter (JCSM).

Her main interest lies in the characterization and biological application of polymers and their formulations. Through her studies of biochemistry, her PhD in biotechnology, in which she dealt with the gene delivery of cationic polymers, and her close cooperation with physicians, Dr. Träger can draw on a broad knowledge in the field of applications of synthetic polymers.

• Publications (peer-reviewed): 44
• Citations: 947 (Researcher ID), 1114 (Google)
• h-Index: 17 (Researcher ID), 20 (Google)
• Patent applications: 6

Prof. Dr. Reinhard Wetzker headed the Institute of Molecular Cell Biology at the University Hospital Jena. His scientific interest is the understanding of signal transduction processes in cells and organisms. His research focuses on the function of the signaling protein phosphoinositide 3-kinase gamma in adaptive stress reactions of biological systems. Prof. Wetzker directs a graduate college of the German Research Foundation with the topic "Molecular Signatures of Adaptive Stress Responses" in Jena.